← Back to Search

Electrical Spinal Stimulation for Spinal Cord Injury (ADDRESS Trial)

N/A
Waitlist Available
Led By Chet T Moritz, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

This trial is testing a new electrical stimulation device to see if it can improve hand motor and sensory function in people with traumatic or degenerative cervical spinal cord injury.

Who is the study for?
This trial is for adults aged 21-70 with a cervical spinal cord injury (C7 or higher) that's at least one year old. Participants should have some hand function issues but be able to do simple tasks and attend weekly therapy sessions. They must not have other major neurological diseases, uncontrolled health conditions like severe hypertension, autoimmune disorders, active cancer, recent botulinum toxin injections, implanted stimulators, or severe mental health issues.
What is being tested?
The study tests if transcutaneous cervical electrical stimulation combined with physical therapy can improve arm and hand functions in those with spinal injuries compared to physical therapy alone. It's a delayed cross-over design: participants first get one treatment then switch to the other. The total study lasts 6 months including baseline measurements, intervention period of 8 weeks and follow-up of 12 weeks.
What are the potential side effects?
Potential side effects are not explicitly listed but may include discomfort from the electrical stimulation device or muscle soreness from increased physical activity during therapy sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Graded and Redefined Assessment of Strength, Sensibility and Prehension test (GRASSP test)
Secondary study objectives
Grip and pinch strength
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Examination
Numeric Pain Rating Scale
+3 more

Trial Design

2Treatment groups
Active Control
Group I: Physical therapy onlyActive Control1 Intervention
Physical therapy that targets rehabilitation of upper extremity functions
Group II: Transcutaneous spinal stimulation & Physical therapyActive Control2 Interventions
Transcutaneous cervical electrical stimulation combined with physical therapy that targets rehabilitation of upper extremity functions

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,791 Previous Clinical Trials
1,905,496 Total Patients Enrolled
Chet T Moritz, PhDPrincipal InvestigatorUniversity of Washington

Media Library

Transcutaneous Spinal Stimulation Clinical Trial Eligibility Overview. Trial Name: NCT03184792 — N/A
Spinal Cord Injury Research Study Groups: Physical therapy only, Transcutaneous spinal stimulation & Physical therapy
Spinal Cord Injury Clinical Trial 2023: Transcutaneous Spinal Stimulation Highlights & Side Effects. Trial Name: NCT03184792 — N/A
Transcutaneous Spinal Stimulation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03184792 — N/A
~1 spots leftby Sep 2025